Pioneer of Biopharmaceutical Research
and Development Transformation
Pioneer of Biopharmaceutical Research
and Development Transformation
Beijing Baheal Chengchuang Pharmaceutical Research and Development Co., Ltd. (Baheal Sinovate) is a wholly-owned subsidiary of Baheal Pharma Group. Operating as the Group’s dedicated medical innovation incubation platform, Baheal Sinovate is committed to nurturing original innovations that can truly optimize medical scenarios. Through allocating comprehensive industrial resources, it advances the development and milestone breakthroughs of early-stage innovation pipelines to create pharmaceutical technologies, products and integrated solutions with independent intellectual property rights, thereby steadily advancing the evolution of China’s biopharmaceutical and healthcare sector.
As a leading early-stage value investor in China's healthcare sector, Baheal Zhongxin Capital, a subsidiary of Baheal Sinovate, is the executive agency for innovation incubation and investment management of Baheal Pharma Group. Baheal Zhongxin Capital boasts a professional investment and financing team, which leverages the group's substantial industrial background and technological innovation resources and provide configuration of elements for innovative enterprises at various stages of their lifecycle. Therefore, this whole process can ensure the success of innovative R&D and the implementation of innovative achievements.
Investment philosophy：Early Stage, New and Innovative and Long-Term Commitment
Learn MoreThrough concentrating on end-to-end incubation process of original innovation pipelines, Baheal Sinovate delivers comprehensive full-lifecycle industrial empowerment based on its specialized and systematic incubation infrastructure. We foster seamless industry-academia collaboration to form a fully closed-loop value ecosystem, accelerating the translational and commercial advancement of lab-derived scientific breakthroughs.
Guided by our mission to elevate real-world clinical care, Baheal Sinovate maintains deep partnerships with national research institutes to establish a series of IP-focused consortia in pharmaceutical and medical devices industries. We have built out an innovative drug and medical device layout with our therapeutic pipelines across key areas: bone health, anti-organ fibrosis, cardiovascular diseases, and oncology.
Address: Building 5, Zhongguancun Science Park Mentougou Park, No.20 Ping'an Road, Mentougou District, Beijing, China
E-mail: bycc@baiyyy.com.cn
Copyright © Beijing Baheal Chengchuang Pharmaceutical Research and Development Co., Ltd. All Rights Reserved.
